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Abstract
In perioperative cardiac surgery period, supra-physiological
arterial oxygen partial pressures is common practice,
although there is no clear evidence of any benefit.
Smit et al. have shown that a “conservative” approach
did not improve hemodynamics, decrease oxidative
stress or myocardial tissue damage, but was not
associated with major deleterious event either. Here,
we outline major oxygen friend or foes properties,
which may partly explain the study results, and place
the clinical trial from Smit et al. in a global context.
Introduction
Targeting supra-physiological arterial oxygen partial
pressures (PaO2) during the perioperative period of
cardiac surgery is common practice [1], but why? The
surgical trauma per se and the ischemia–reperfusion se-
quence associated with cardiopulmonary bypass (CPB)
cause hyper-inflammation and excessive release of react-
ive oxygen species (ROS). Any alveolar, arterial, and/or
tissue hypoxia also triggers hyper-inflammation, and car-
diac surgery may induce an imbalance between tissue
oxygen delivery (DO2) and oxygen consumption (VO2)
due to myocardial dysfunction, vasoplegia, microcircula-
tion alterations, hypothermia, anemia, and hypovolemia.
High inspiratory oxygen concentrations (FiO2) can the-
oretically counteract this problem, but so far the optimal
targets for PaO2 during CPB and/or the immediate post-
operative ICU stay remain open [1].
Main text
Recently, Smit et al. [2] investigated whether a “conserva-
tive” oxygen approach targeting a “near-physiological”
PaO2 of 130–150 and 80–100 mmHg during CPB and in
the first 12 hours of ICU stay, respectively, would improve
hemodynamics, reduce oxidative stress, and attenuate
myocardial damage and visceral organ dysfunction. The
control group received standard care; that is, PaO2 targets
were 200–220 and 130–150 mmHg during CPB and early
ICU stay, respectively. The main results were that the
“conservative” approach did not improve hemodynamics,
and neither attenuated oxidative stress (assessed by the
plasma isoprostane levels and the ex-vivo ROS release in
polymorphonuclear leukocytes) nor myocardial tissue
damage (assessed by troponin-T levels and myocardial
creatinine kinase (CK-MB) activity). However, the “conser-
vative” strategy was not associated either with major
hyperlactatemia, visceral organ dysfunction (assessed by
plasma creatinine levels), or hypoxic events (defined by
PaO2 < 55 mmHg).
Hyperoxia has “friend-and-foe” properties, both in
critically ill patients in general [3] and specifically in
cardiac surgery patients [1]. Perioperative hyperoxia per
se can improve oxidative killing of bacteria [3], since
bactericidal properties of neutrophils depend on the PO2
in the contaminated tissue. In fact, the most recent
meta-analysis on this subject including nine studies
comprising 5103 patients concluded that perioperative
hyperoxia may reduce surgical site infection, in particu-
lar in patients undergoing colorectal surgery [4]. Never-
theless, given the negative result of the large-scale,
multicenter, randomized “Supplemental Oxygen and
Complications After Abdominal Surgery” (PROXI) trial,
the most recent Cochrane review [5] concluded that, so
far, robust evidence is lacking to recommend the use of
high FiO2 during the perioperative period, and may even
be responsible for adverse events. In fact, the use of peri-
operative hyperoxia has been cautioned by the data on the
long-term follow-up (up to 3 years) of the PROXI trial:
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hyperoxia increased long-term mortality, and this was due
to the subgroup of patients undergoing cancer surgery [6],
who showed a reduction in cancer-free survival [7].
Perioperative hyperoxia might also allow for myocardial
ischemia-preconditioning in cardiac surgery [8]. Con-
versely, it may exacerbate the transitory CPB-related pul-
monary injury due to increased oxidative stress and
aggravated systemic inflammatory response [9]. Finally,
hyperoxia may also affect hemodynamics during and after
cardiac surgery due to systemic vasoconstriction, de-
creased heart rate, and direct negative inotropic ef-
fects, overall decreasing cardiac output [2, 3]. It is
well established that hyperoxia-induced vasoconstriction
is particularly pronounced in the coronary circulation
[10], thus possibly increasing susceptibility to myocardial
ischemia and ischemia–reperfusion-induced injury in pa-
tients with coronary artery disease (CAD) [2, 3]. In nonhy-
poxemic patients, the AVOID trial [11] showed that high-
flow O2 therapy during ST-segment elevation myocardial
infarction increased CK-MB activity, which coincided with
higher Troponin-I levels (p = 0.12) and infarct size
(p = 0.06). Interestingly, albeit not significantly different
(p = 0.11), mortality at hospital discharge was 2.5-fold
higher in the normoxia group. Hyperoxia pre-treatment
(as during cardiac surgery) may prolong the “window
of opportunity” prior to myocardial ischemia: high-
flow O2 increased the time to onset of both pacing-
induced and exercise-induced myocardial ischemia in
CAD patients [12, 13].
What do we learn from the study by Smit et al. [2]?
The “conservative” approach did not beneficially affect
the parameters assessed, but had no deleterious side ef-
fects either. Signs of possible tissue hypoperfusion (i.e.,
lactate levels) only showed a mild increase (maximum
2 mmol/l) independently of the group assignment, and
none of the patients showed major organ dysfunction. It
remains unclear whether the “conservative” approach
substantially altered DO2 and/or VO2: the cardiac index
and total hemoglobin content were comparable, and the
time-weighted PaO2 values (220 vs. 157 mmHg, 214 vs.
147 mmHg, and 107 vs. 90 mmHg during CPB, aortic-
cross clamping, and ICU stay, respectively) suggest that
there were no major differences in hemoglobin O2 satur-
ation. Since neither glycemia nor data on insulin require-
ments are reported, it remains open whether there was
any difference in metabolic substrate utilization: increas-
ing FiO2 was reported to reduce O2 uptake in critically ill
patients and, eventually, switch energy metabolism to
preferential carbohydrate use [3]. Finally, as the authors
acknowledge themselves, the systematic dexamethasone
administration after induction of anesthesia may have mit-
igated any further effect of the different O2 strategy.
Nevertheless, the results presented by Smit et al. are of
major interest and clinical importance given the current
practice comprising administration of high FiO2 levels
and targeting supra-physiological PaO2 values in cardiac
surgery. Previous studies have already suggested that more
conservative O2 targets might be beneficial [14, 15]. How-
ever, in these studies the “hyperoxic” groups had PaO2
levels of 400–500 mmHg during CPB, and the “lower”, so-
called “normoxic” groups were titrated to PaO2 levels of
140 mmHg [14] and 200–250 mmHg [15], respectively;
that is, close to the targets of the hyperoxic “control” arm
in the present investigation. Moreover, PaO2 strategies
were only modified during CPB, whereas Smit et al. also
targeted the early ICU stay.
Conclusion
Despite some study limitations, Smit et al. have to be
commended for performing an elegant clinical trial on
routine procedures that had so far never undergone rigor-
ous testing under randomized, controlled conditions. The
results of their much larger “Optimal Oxygenation in the
Intensive Care Unit (O2-ICU)” trial (ClinicalTrials.gov
NCT02321072) comparing high-normal vs. low-normal
(120 vs. 75 mmHg) PaO2 targets in ICU patients is there-
fore eagerly awaited.
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